Geraniol demonstrates significant cardioprotective activity in diabetic models, primarily through attenuating oxidative stress. This natural monoterpenoid is used in research exploring diabetic cardiomyopathy, with studies showing efficacy in both in vivo rodent models and in vitro cardiomyocyte assays.
